STOCK TITAN

Penumbra Inc - PEN STOCK NEWS

Welcome to our dedicated news page for Penumbra (Ticker: PEN), a resource for investors and traders seeking the latest updates and insights on Penumbra.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Penumbra's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Penumbra's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.68%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.76%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.88%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.18%
Tags
none
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Stock Data

8.76B
37.19M
3.82%
89.82%
5.1%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Alameda

About PEN

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.